INTRODUCTION {#s1}
============

Amyloid precursor-like protein 1 (APLP1) is a member of the highly conserved amyloid precursor protein family that includes amyloid precursor protein (APP) and amyloid precursor-like protein 2 (APLP2) in mammals \[[@R1]--[@R4]\]. Members of this family are type I integral membrane proteins that contain a single transmembrane domain with a large N-terminal extracellular domain and a short C-terminal intracellular domain (AICD) \[[@R5]\]. While APP has been studied extensively as the precursor of amyloid beta (Aβ) peptides implicated in the pathogenesis of Alzheimer\'s disease (AD) \[[@R6]\], the physiological functions of APP have yet to be fully elucidated. Previous studies have suggested a role of APP in neurogenesis \[[@R7], [@R8]\], neurite outgrowth \[[@R9]--[@R12]\], axonal pruning \[[@R13]\], synapse formation and function \[[@R14]--[@R16]\], cargo transport along the axon \[[@R17]--[@R20]\], cell death \[[@R21]\] and cell fate determination \[[@R22]\].

APP family proteins have also been implicated in neuronal migration, yet this function has been controversial. It was originally reported that neurons in APP/APLP1/APLP2 triple knockout mice over-migrated and accumulated in the marginal zone \[[@R23]\], suggesting that APP family proteins negatively regulate neuronal migration. Yet, APP triple knockout neurons differentiated from APP triple knockout embryonic stem (ES) cells have unaltered migratory capacities both *in vivo* and *in vitro* \[[@R24]\], and down-regulation of APLP2 in APP/APLP1 double knock mice did not affect the migration of cortical neurons \[[@R25]\]. RNAi knock-down of APP in the developing cortex blocked the migration of neurons from the intermediate zone to the cortical plate \[[@R26]\], suggesting a positive role of APP in neuronal migration. However, this phenotype was not resulted from a general defect in cell motility, rather, a specific defect in the interaction between APP ectodomain and the extracellular factors, such as pancortins were detected \[[@R27]\]. Furthermore, cultured CHO cells overexpressing APLP2 exhibited an enhanced migratory response to fibronnectin and type IV collagen through increased adhesion to these extracellular molecules \[[@R28]\]. Together, these studies suggest that APP and APLP2 are required for cell adhesion with extracellular factors, yet a direct role of APP family proteins in promoting cell migration has not been documented.

Though APP family proteins have conserved structure and could compensate for each other to certain extent in double and triple knockout mice \[[@R23]\], APLP1 likely carries out distinct physiological functions from APP and APLP2. First, APLP1 is mainly localized to the cell surface, whereas APP and APLP2 are mostly found in intracellular compartments \[[@R29]\]. Second, APLP1, but not APP and APLP2, interacts in trans and is involved in cell-cell contacts \[[@R29]\]. Third, APLP1 does not undergo the same type of regulated processing as APP and APLP2 \[[@R30]\]. Despite a few studies on the processing and expression of APLP1, the functions of APLP1 remain largely unknown. APLP1 is reported to be a p53 transcriptional target that modulates stress-induced apoptosis \[[@R31]\], and is up-regulated in neuroendocrine tumors of the gastrointestinal tract \[[@R32]\].

The c-Jun N-terminal Kinase (JNK) pathway is evolutionarily conserved from *Drosophila* to human, and regulates a wide range of cellular activities including proliferation, differentiation, migration and apoptosis \[[@R33]\]. Recently, JNK pathway was shown to play important roles in modulating Src-induced cell migration \[[@R34]\] and Aβ induced cell death in *Drosophila* \[[@R35], [@R36]\]. However, a functional connection between JNK and APLP1 has not been established.

*Drosophila* has been used as an animal model to study the *in vivo* function of APP, for the genetics of *Drosophila* is clear and *Drosophila* is easy to manipulate. In *Drosophila*, there is also an APP-like protein, APPL, indicating the role of APPL may be conserved from *Drosophila* to human. In this report, we investigate the function of APLP1 in *Drosophila*. We found that expression of APLP1 in *Drosophila* wing disc triggers cell migration, which is suppressed by the loss of JNK signaling and enhanced by the gain of JNK signaling. APLP1 activates JNK signaling through phosphorylation of JNK, which results in elevated expression of JNK target genes including *puc* and *mmp1*, and actin polymerization. Thus, this work provides the first evidence that APLP1 promotes JNK-dependent cell migration *in vivo*.

RESULTS {#s2}
=======

APLP1 induces cell migration in *Drosophila* wing discs {#s2_1}
-------------------------------------------------------

To investigate the physiological functions of APLP1 in development, we adopted the Gal4/UAS system to express APLP1 in various tissues in *Drosophila*. Interestingly, expression of APLP1 along the anterior/posterior (A/P) compartment boundary in third-instar wing discs under the control of *patched*-Gal4 (Figures [1a and 1a\'](#F1){ref-type="fig"}), a driver commonly used to study cell migration behavior in *Drosophila* \[[@R37], [@R38]\], produced cell migration phenotype. The green fluorescent protein (GFP) labeled cells are detached from the A/P compartment boundary and migrates toward the posterior part of the wing discs (Figures [1b and \'](#F1){ref-type="fig"}). This phenotype was further enhanced by adding another copy of *UAS*-APLP1 (Figures [1c and 1c\'](#F1){ref-type="fig"}), as the number of discs showing strong migration was increased from 63% to 84% (Figure [1e](#F1){ref-type="fig"}).

![APLP1 induces cell migration in *Drosophila*\
Fluorescence micrographs of wing discs are shown. Compared with the *ptc*-Gal4 *UAS*-GFP control (**a**, **a\'**), expression of APLP1 induced moderate cell migration behavior (**b**, **b\'**) that was enhanced by adding another copy of APLP1 **(c**, **c\')**. As a positive control, expression of Egr produced a similar cell migration phenotype (**d**, **d\'**). **a\'**-**d\'** are high magnifications of **a**-**d**. (**e**) Quantification of migration phenotype. The migration phenotype was classified into four groups based on the number of GFP-labeled cells migrated to the posterior compartment. None: no GFP-labeled cells; Weak: 1-5 cells; Moderate: 6-20 cells; Strong: \>20 cells. More than 20 discs were examined for each genotype. The crosses were performed at 29°C.\*\*\*, P\<0.001; \*\*, P\<0.01. The genotypes used in the figure are as follows: *ptc*-Gal4 *UAS*-GFP/+ (**a**, **a\'**), *ptc*-Gal4 *UAS*-GFP/+; *UAS*-APLP1/+ (**b**, **b\'**), *ptc*-Gal4 *UAS*-GFP/+; *UAS*-APLP1/*UAS*-APLP1 (**c**, **c\'**) and *ptc*-Gal4 *UAS*-GFP/+; *UAS*-Egr/+ (**d**, **d\'**).](oncotarget-08-49725-g001){#F1}

The JNK signaling was reported to play a pivotal role in regulating cell migration in *Drosophila* \[[@R33], [@R39], [@R40]\]. Consistently, activation of JNK signaling by expressing the *Drosophila* TNF ortholog Egr \[[@R41], [@R42]\], or the JNK kinase Hep \[[@R43]\], produces a similar migration phenotype (Figures [1d, 1d\' and 1e](#F1){ref-type="fig"} and data not shown). Thus, expression of APLP1 in *Drosophila* recapitulates that of JNK activation and promotes cell migration.

JNK signaling is required for APLP1-induced cell migration {#s2_2}
----------------------------------------------------------

To investigate whether JNK signaling is involved in APLP1-induced cell migration, we first enhanced the JNK signaling by mutating one cope of endogenous *puckered* (*puc*) gene. *puc* encodes a JNK phosphatase that negatively regulates JNK activity \[[@R44], [@R45]\]. We found that APLP1-induced cell migration phenotype (Figure [2b](#F2){ref-type="fig"}) was significantly exacerbated by two independent *puc* mutants (Figures [2c and 2d](#F2){ref-type="fig"}), which by themselves produced no evident cell migration phenotype (Figures [2h and 2i](#F2){ref-type="fig"}). As a positive control, *ptc*\> Egr induced cell migration was also enhanced by *puc* mutant ([Supplementary Figure 1d](#SD1){ref-type="supplementary-material"}). Thus, gain of JNK signaling could exaggerate APLP1-induced cell migration.

![APLP1-induced cell migration depends on JNK signaling\
Fluorescence micrographs of wing discs are shown. Compared with the *ptc*-Gal4 *UAS*-GFP control (**a**, **a\'**), APLP1-induced cell migration (**b**) was enhanced in heterozygous *puc* mutants (**c**, **d**), and was blocked by expression of Bsk^DN^ (**e**) or Puc (**f**), but not by that of *LacZ* (**g**). The *puc* mutants did not produce migration phenotype by themselves (**h**, **i**). (**j**) Quantification of migration phenotype in **a**-**i**. The crosses were performed at 29°C. \*\*\*, P \<0.001, n.s., no significance. The genotypes used in the figure are as follows: *ptc*-Gal4 *UAS*-GFP/+ (**a**, **a\'**), *ptc*-Gal4 *UAS*-GFP/+; *UAS*-APLP1/+ (**b**), *ptc*-Gal4 *UAS*-GFP/+; *UAS*-APLP1/*puc*^E69^ (**c**), *ptc*-Gal4 *UAS*-GFP/+; *UAS*-APLP1/*puc*^H246^ (**d**), *ptc*-Gal4 *UAS*-GFP/+; *UAS*-APLP1/*UAS*-Bsk^DN^ (**e**), *ptc*-Gal4 *UAS*-GFP/+; *UAS*-APLP1/*UAS*-Puc (**f**), *ptc*-Gal4 *UAS*-GFP/+; *UAS*-APLP1/*UAS*-*LacZ* (**g**), *ptc*-Gal4 *UAS*-GFP/+; *puc*^E69^/+ (**h**) and *ptc*-Gal4 *UAS*-GFP/+; *puc*^H246^/+ (**i**).](oncotarget-08-49725-g002){#F2}

To examine whether loss of JNK signaling could suppress APLP1-triggered cell migration, we expressed a dominant negative form of Bsk (Bsk^DN^) encoding the *Drosophila* JNK \[[@R46]\], or the JNK phosphatase Puc. APLP1-induced cell migration was completely blocked by expression of Bsk^DN^ (Figures [2e and 2j](#F2){ref-type="fig"}) or Puc (Figures [2f and 2j](#F2){ref-type="fig"}), but not by that of *LacZ* (Figures [2g and 2j](#F2){ref-type="fig"}). Consistently, the *puc* mutant-enhanced APLP1-induced cell migration phenotype was also suppressed by expression of Bsk^DN^ ([Supplementary Figures 1e and 1g](#SD1){ref-type="supplementary-material"}) or Puc ([Supplementary Figures 1f and 1g](#SD1){ref-type="supplementary-material"}). In conclusion, JNK signaling is absolutely required for APLP1-induced cell migration in *Drosophila*.

We also checked APLP2, amyloid precursor-like protein 2, in cell migration. Expression of APLP2 induced moderate cell migration phenotype (data not shown), which was consistent with APLP1 in cell migration, indicating a universal role of APLPs in cell migration. To examine whether APLP1 induced JNK-mediated cell migration is conserved from *Drosophila* to human beings, we checked APPL, a *Drosophila* APP-like protein \[[@R47]\], in cell migration. Consistent with our hypothesis, expression of APPL driven by *ptc*-Gal4 induced significant cell migration phenotype, which was suppressed by expression of Bsk^DN^ ([Supplementary Figures 2c, 2c\' and 2f](#SD1){ref-type="supplementary-material"}) or Puc ([Supplementary Figures 2d, 2d\' and 2f](#SD1){ref-type="supplementary-material"}) and exacerbated by *puc* mutant ([Supplementary Figures 2e, 2e\' and 2f](#SD1){ref-type="supplementary-material"}). Collectively, the results revealed that APPL and APLP1 induced JNK-mediated cell migration, indicating cell migration function of APLP1 is conserved and is not obtained later in evolution.

APLP1 induces JNK phosphorylation and *puc* activation in *Drosophila* {#s2_3}
----------------------------------------------------------------------

The above data indicates that APLP1 is able to trigger JNK-dependent cell migration in *Drosophila*. To check if APLP1 could activate JNK signaling *in vivo*, we examined the expression of *puc*-LacZ reporter, a read-out of JNK signaling \[[@R45], [@R48]\], and JNK phosphorylation in the wing discs. Compared with the control (Figures [3a-3a\'\'\', 3e-3e\'\'](#F3){ref-type="fig"}), expression of APLP1 induced both *puc-*LacZ expression (Figures [3b-3b\'\'\'](#F3){ref-type="fig"}) and JNK phosphorylation (Figures [3f-3f\'\'](#F3){ref-type="fig"}), which were blocked by expression of Bsk^DN^ (Figures [3c-3c\'\'\', 3g-3g\'\'](#F3){ref-type="fig"}) or Puc (Figures [3d-3d\'\'\', 3h-3h\'\'](#F3){ref-type="fig"}), suggesting APLP1 is able to activate JNK signaling *in vivo*.

![APLP1 activates JNK signaling *in vivo*\
Fluorescence (**a-a"**, **b-b"**, **c-c"**, **d-d"**, **e-e"**, **f-f"**, **g-g"**, **h-h"**) and light (**a\'\'\'**, **b\'\'\'**, **c\'\'\'**, **d\'\'\'**) micrographs of wing disc are shown. Compared with the *ptc*-Gal4 *UAS*-GFP control (**a**-**a\'\'\'**, **e-e"**), expression of APLP1 activated *puc* expression, detected by β-gal antibody (**b-b"**) or X-gal staining (**b\'\'\'**), and JNK phosphorylation (**f**-**f\'\'**), which were suppressed by expression of Bsk^DN^ (**c**-**c\'\'\'**, **g**-**g\'\'**) or Puc (**d**-**d\'\'\'**, **h**-**h\'\'**). The crosses were performed at 25°C. The genotypes used in the figure are as follows: *ptc*-Gal4 *UAS*-GFP/+; *puc*-LacZ/+ (**a-a"\'**, **e-e\'\'**), *ptc*-Gal4 *UAS*-GFP/+; *puc*-LacZ/*UAS*-APLP1 (**b-b"\'**, **f-f\'\'**), *ptc*-Gal4 *UAS*-GFP/+; *puc*-LacZ/*UAS*-APLP1 *UAS*-Bsk^DN^ (**c-c\'\'\'**, **g-g\'\'**), *ptc*-Gal4 *UAS*-GFP/+; *puc*-LacZ/*UAS*-APLP1 *UAS*-Puc (**d-d\'\'\'**, **h-h\'\'**).](oncotarget-08-49725-g003){#F3}

To investigate whether APLP1 could activate JNK signaling in different cellular contexts, we directed APLP1 expression by other Gal4 drivers. We found that APLP1 expression driven by *engrailed*-Gal4 (*en*-Gal4) triggered *puc*-LacZ expression ([Supplementary Figures 3c-3c\'\'\'](#SD1){ref-type="supplementary-material"}) and JNK phosphorylation ([Supplementary Figures 3d-3d\'\'](#SD1){ref-type="supplementary-material"}) in the posterior compartment of wing discs, which was suppressed by the expression of Bsk^DN^ ([Supplementary Figures 3e-3e\'\', 3f-3f\'\'](#SD1){ref-type="supplementary-material"}). In addition, APLP1 expression in the wing pouch driven by *scalloped*-Gal4 (s*d*-Gal4) or in the salivary gland also activates JNK signaling, resembling that of Hep expression ([Supplementary Figure 4](#SD1){ref-type="supplementary-material"}). Collectively, the data indicate that APLP1 is able to trigger JNK activation in various cellular contexts in *Drosophila*. Consistently, expression of *Drosophila* APPL also upregulated JNK signaling in the wing discs ([Supplementary Figure 5b-5b\'\'\'](#SD1){ref-type="supplementary-material"}), demonstrating APLP1 induced JNK activation is conserved in evolution.

APLP1 induces JNK mediated MMP1 expression and actin polymerization {#s2_4}
-------------------------------------------------------------------

Previous studies have suggested that JNK-dependent cell migration is mediated by transcriptional up-regulation of the matrix metalloproteinase MMP1, which is required for the degradation of basement membranes \[[@R33], [@R49]--[@R53]\]. Consistently, expression of APLP1 driven by *ptc*-Gal4 up-regulated MMP1 expression in the A/P boundary and posterior compartment (Figures [4a-4a\'\', 4b-4b\'\'](#F4){ref-type="fig"}), which was blocked by inactivation of JNK signaling (Figures [4c-4c\'\'](#F4){ref-type="fig"}). Intriguingly, APLP1 expression driven by *en*-Gal4 triggered GFP-labeled cells to migrate from the posterior compartment toward anteriorly with elevated MMP1 expression ([Supplementary Figures 6a-6a\'\', 6b-6b\'\'](#SD1){ref-type="supplementary-material"}), a phenotype that was inhibited by inactivation of JNK signaling ([Supplementary Figures 6c-c\'\'](#SD1){ref-type="supplementary-material"}). Previous work suggested JNK signaling-dependent actin remodeling is required for cell migration \[[@R53], [@R54]\]. Consistent with its ability to activate JNK signaling, APLP1 expression induced actin polymerization in *ptc* domain and migrated cells (Figures [4d-4d](#F4){ref-type="fig"}", 4e-4e\'\'), which was abrogated by blocking JNK signaling (Figures [4f-4f\'\'](#F4){ref-type="fig"}). Taken together, APLP1 induces JNK-dependent MMP1 expression and actin polymerization, which are required for basement membranes degradation and cell motility, respectively \[[@R52], [@R55], [@R56]\]. Consistently, downregulation of MMP1 and MMP2 or expression of tissue inhibitor of matrix metalloprotease-1 (TIMP1) \[[@R57]--[@R59]\] compromised APLP1 induced cell migration phenotype ([Supplementary Figures 7b-7f](#SD1){ref-type="supplementary-material"}). Rho GTPases play an important role in diverse biological processes such as actin cytoskeleton organization \[[@R60], [@R61]\]. As expected, loss of Rho-1 moderately suppressed APLP1 induced cell migration phenotype ([Supplementary Figures 8a-8d](#SD1){ref-type="supplementary-material"}), further indicating APLP1 induced actin-remodeling is required for the cell migration phenotype.

![APLP1 induces JNK-dependent MMP1 expression and actin remodeling\
Fluorescence micrographs of wing discs are shown (**a-f**). Compared with the *ptc*-Gal4 *UAS*-GFP control (**a-a\'\'**, **d-d"**), expression of APLP1 activated MMP1 expression (**b-b\'\'**) and actin polymerization (**e-e"**, indicated by white arrows), both were blocked by expression of Bsk^DN^ (**c-c\'\'**, **f**-**f\'\'**). A model for APLP1-induced JNK-dependent cell migration was shown (**g**). The crosses were performed at 29°C. The genotypes used in the figure are as follows: *ptc*-Gal4 *UAS*-GFP/+; *puc*-LacZ/+ (**a-a\'\'**, **d**-**d"**), *ptc*-Gal4 *UAS*-GFP/+; *puc*-LacZ/*UAS*-APLP1 (**b-b\'\'**, **e**-**e"**), *ptc*-Gal4 *UAS*-GFP/+; *puc*-LacZ/*UAS*-APLP1 *UAS*-Bsk^DN^ (**c-c\'\'**, **f**-**f\'\'**).](oncotarget-08-49725-g004){#F4}

DISCUSSION {#s3}
==========

In this study we provide evidence demonstrating a direct role of APLP1 in promoting cell migration *in vivo*. This function of APLP1 depends on JNK signaling, as gain of JNK signaling boosts whereas loss of JNK signaling blocks APLP1-induced cell migration. Mechanistically, APLP1 expression induces JNK phosphorylation and subsequent activation of JNK signaling, which leads to transcriptional up-regulation of MMP1 and actin polymerization (Figure [4g](#F4){ref-type="fig"}). Thus, our study indicates a possible role of APLP1 in cell migration in mammals. We previously found expression of APLP1 induced caspase activation and FoxO mediated cell death in *Drosophila* \[[@R62]\], thus we checked if inhibiting of caspase could suppress APLP1 induced cell migration phenotype. Expression of baculovirus *p35*, which prevents cell death in *Drosophil*a \[[@R63]\], failed to rescue APLP1 induced cell migration phenotype ([Supplementary Figures 9d](#SD1){ref-type="supplementary-material"}) and along the A/P boundary we observed a broadened GFP labelled cells ([Supplementary Figures 9d](#SD1){ref-type="supplementary-material"}). P53 is known to interact with JNK signaling \[[@R64]--[@R67]\], we found that expression of a dominant negative form of P53 had no evident suppression of APLP1 induced cell migration phenotype ([Supplementary Figures 9c](#SD1){ref-type="supplementary-material"}), indicating APLP1 induced JNK-mediated cell migration independent of P53 or caspase activation. Loss of cell polarity genes, such as *scrib* and *lgl*, not only induces JNK-dependent cell migration in wing disc epithelia, but also shows oncogenic cooperation with activated Ras in eye discs to promote tumor growth and invasion \[[@R40]\], thus we checked if APLP1 cooperated with oncogenetic Ras in promoting tumor progression. Yet, expression of APLP1 had no significant cooperating effect with Ras in the tumor progression ([Supplementary Figures 10a-10c\'](#SD1){ref-type="supplementary-material"}), indicating APLP1 induced cell migration may be through a different pathway.

Consistent with our findings, APLP1 has been found to be significantly up-regulated in several types of human cancers including invasive ductal breast carcinoma (<https://tcga-data.nci.nih.gov/docs/publications/tcga/>) and lung carcinoid tumor \[[@R68]\] (Figure [5a and 5b](#F5){ref-type="fig"}). In addition, based on the outlier analysis from the Oncomine database (<https://www.oncomine.org/>), many more cancers, including Esophageal cancer, Ovarian cancer, Sarcoma, and Kidney cancer, have a portion of samples showing significantly higher expression of APLP1 in multiple studies, suggesting APLP1 may play an important role in some subtypes of cancers during tumorigenesis. Finally, higher APLP1 expression was observed in more advanced stages in lung cancer \[[@R69]\] (Figure [5c](#F5){ref-type="fig"}), implying a role of APLP1 in tumor metastasis.

![APLP1 is up-regulated in certain types of human cancer, and its higher expression may be correlated with more advanced stages in lung cancer\
The following data analysis all came from Oncomine database: (**a**) TCGA Breast cancer data showed that APLP1 expression was significantly up-regulated in invasive ductal breast carcinoma compared to the normal control. Fold change=2; P value=1.03E-31; (**b**) In Bhattacharjee Lung study, APLP1 expression was up-regulated significantly in lung carcinoid tumor compared to the normal control. Fold change=53.5; P value=2.01E-8; **(c**) In Selamat Lung study, outlier analysis at 75^th^ percentile was performed for APLP1 expression. APLP1 expression increased markedly from stages IA to IB and IIA above 75^th^ percentile. Sample size for stages IIB and IV was too small to be considered. COPA=1.791.](oncotarget-08-49725-g005){#F5}

MATERIALS AND METHODS {#s4}
=====================

Fly genetics {#s4_1}
------------

All stocks were raised on standard *Drosophila* media and crosses were performed at 25°C unless otherwise indicated. *UAS*-APLP1, *UAS*-APPL^sd^ were kindly provided by Dr. Merdes \[[@R22]\]; *puc*^H246^, *UAS-mmp1*-IR, *UAS-mmp2*-IR, *UAS*-TIMP1, *UAS*-Ras^V12^, *UAS*-*Rho1*-IR, *UAS*-*p35*, UAs-*P53*^DN^ were obtained from Bloomington Stock Center; *sd*-Gal4, *UAS*-Bsk^DN^, *UAS*-Puc, *UAS*-Egr, *UAS*-Hep \[[@R70]\]; *ptc*-Gal4, *en*-Gal4, *puc*^E69\ 34^, *UAS*-LacZ \[[@R71]\] were previously described.

Statistical analysis {#s4_2}
--------------------

For statistical analysis of cell migration, 20-30 3^rd^ instar larvae were dissected for each genotype as described \[[@R53]\]. Discs were separated to different categories based on the number of cells migrated to the posterior compartments.

Immunohistochemistry {#s4_3}
--------------------

Antibody staining of the imaginal discs was performed as previously described \[[@R40]\]. The following antibodies were used: mouse anti-β-gal (1:400, Developmental Studies Hybridoma Bank), mouse anti-MMP1 (1:100, Developmental Studies Hybridoma Bank), rabbit anti-phospho-JNK (1:200, Calbiochem), phalloidin (1:400, Sigma). Secondary antibodies were anti-rabbit-Alexa (1:1000, Cell Signaling and Technology) and anti-mouse-Cy3 (1:1000, Jackson ImmunoResearch).

For X-gal staining, 3^rd^ instar larvae wing discs were dissected in PBST and stained for β galactosidase activity as described \[[@R72]\].
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=====================
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